LAMA-87 Human Chronic Myeloid Leukemia Cell Line

The LAMA-87 human chronic myeloid leukemia cell line is an erythroeosinophilic cell line derived from LAMA-84 (2). LAMA-87 cells are positive for the BCR-ABL gene translocation (3) and express erythrocytic markers such as glycophorin A, as well as the CD33 granulomonocytic marker CD33, which distinguishes CML from other leukemias (2). When inoculated into non-treated athymic mice, LAMA-87 cells can differentiate to give rise to eosinomonocytic cells (2).

Source:
The LAMA-87 cell line was derived from LAMA-84 human chronic myeloid leukemia cells inoculated into estrone-treated athymic mice (2). The parent LAMA-84 cell line was isolated from leukemia of a 29-year-old female patient (3).

Research Category:
Cancer

Human, Cancer Cells

≥1X10⁶ cells/vial

Store in liquid nitrogen. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

This product is intended for sale and sold solely to academic institutions for internal academic research use per the terms of the “Academic Use Agreement” as detailed in the product documentation. For information regarding any other use, please contact licensing@emdmillipore.com.

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.